Your browser doesn't support javascript.
loading
Bispecific Antibodies for IFN-ß Delivery to ErbB2+ Tumors.
Rybchenko, Vladislav S; Panina, Anna A; Aliev, Teimur K; Solopova, Olga N; Balabashin, Dmitry S; Novoseletsky, Valery N; Dolgikh, Dmitry A; Sveshnikov, Petr G; Kirpichnikov, Mikhail P.
Afiliação
  • Rybchenko VS; Department of Bioengineering, Shemyakin & Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
  • Panina AA; Department of Bioengineering, Shemyakin & Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
  • Aliev TK; Department of Chemistry, M.V. Lomonosov Moscow State University, 119234 Moscow, Russia.
  • Solopova ON; Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, 115478 Moscow, Russia.
  • Balabashin DS; Russian Research Center for Molecular Diagnostics and Therapy, 117638 Moscow, Russia.
  • Novoseletsky VN; Department of Bioengineering, Shemyakin & Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
  • Dolgikh DA; Department of Biology, M.V. Lomonosov Moscow State University, 119234 Moscow, Russia.
  • Sveshnikov PG; Department of Bioengineering, Shemyakin & Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia.
  • Kirpichnikov MP; Department of Biology, M.V. Lomonosov Moscow State University, 119234 Moscow, Russia.
Biomolecules ; 11(12)2021 12 20.
Article em En | MEDLINE | ID: mdl-34944558

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fragmentos Fc das Imunoglobulinas / Interferon beta / Anticorpos Biespecíficos / Receptor ErbB-2 / Trastuzumab / Neoplasias Limite: Humans Idioma: En Revista: Biomolecules Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Federação Russa

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fragmentos Fc das Imunoglobulinas / Interferon beta / Anticorpos Biespecíficos / Receptor ErbB-2 / Trastuzumab / Neoplasias Limite: Humans Idioma: En Revista: Biomolecules Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Federação Russa